231 related articles for article (PubMed ID: 27768120)
1. Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival.
Gerring RC; Ott CT; Curry JM; Sargi ZB; Wester ST
Eye (Lond); 2017 Mar; 31(3):379-388. PubMed ID: 27768120
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
3. Orbital exenteration for advanced periorbital skin cancers: 20 years experience.
Nassab RS; Thomas SS; Murray D
J Plast Reconstr Aesthet Surg; 2007; 60(10):1103-9. PubMed ID: 17434350
[TBL] [Abstract][Full Text] [Related]
4. Orbital exenteration in periorbital malignancies.
Roche P; Timon C
Surgeon; 2012 Aug; 10(4):189-93. PubMed ID: 22818275
[TBL] [Abstract][Full Text] [Related]
5. Orbital exenteration: A 20-year experience from a tertiary center in Taiwan.
Wang WY; Liao SL; Wei YH
J Formos Med Assoc; 2021 Jul; 120(7):1493-1499. PubMed ID: 33191092
[TBL] [Abstract][Full Text] [Related]
6. Orbital Exenteration to Manage Infiltrative Sinonasal, Orbital Adnexal, and Cutaneous Malignancies Provides Acceptable Survival Outcomes: An Institutional Review, Literature Review, and Meta-Analysis.
Hoffman GR; Jefferson ND; Reid CB; Eisenberg RL
J Oral Maxillofac Surg; 2016 Mar; 74(3):631-43. PubMed ID: 26475973
[TBL] [Abstract][Full Text] [Related]
7. Orbital Exenteration for Advanced Periocular Adnexal Malignancies: Curative Versus Palliative Surgical Intent.
Malik M; Vahdani K; Rose GE; Daniel C; Uddin JM; Verity DH; Collin JRO
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):387-392. PubMed ID: 35093991
[TBL] [Abstract][Full Text] [Related]
8. Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series.
Aryasit O; Preechawai P; Hirunpat C; Horatanaruang O; Singha P
BMC Ophthalmol; 2018 Jul; 18(1):186. PubMed ID: 30055580
[TBL] [Abstract][Full Text] [Related]
9. Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.
Nagendran ST; Lee NG; Fay A; Lefebvre DR; Sutula FC; Freitag SK
Orbit; 2016 Aug; 35(4):199-206. PubMed ID: 27322708
[TBL] [Abstract][Full Text] [Related]
10. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
Furdova A; Lukacko P
J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
[TBL] [Abstract][Full Text] [Related]
11. Orbital exenteration: Institutional review of evolving trends in indications and rehabilitation techniques.
Kiratli H; Koç İ
Orbit; 2018 Jun; 37(3):179-186. PubMed ID: 29039986
[TBL] [Abstract][Full Text] [Related]
12. Multicentred international review of orbital exenteration and reconstruction in oculoplastic and orbit practice.
Zhang Z; Ho S; Yin V; Varas G; Rajak S; Dolman PJ; McNab A; Heathcote JG; Valenzuela A
Br J Ophthalmol; 2018 May; 102(5):654-658. PubMed ID: 28844052
[TBL] [Abstract][Full Text] [Related]
13. Extended orbital exenteration in the treatment of advanced periocular skin cancer with primary reconstruction with a galeacutaneous flap.
Kovacevic PT; Visnjic MM; Kovacevic TT; Radojkovic MR; Stojanovic MR
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(6):325-9. PubMed ID: 19995251
[TBL] [Abstract][Full Text] [Related]
14. Orbital exenteration: a 10-year experience of a general oncology hospital.
Soysal HG
Orbit; 2010 Jun; 29(3):135-9. PubMed ID: 20497078
[TBL] [Abstract][Full Text] [Related]
15. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture.
Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD
Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492
[TBL] [Abstract][Full Text] [Related]
16. Management of neglected periorbital squamous cell carcinoma requiring orbital exenteration.
Karabekmez FE; Selimoglu MN; Duymaz A; Karamese MS; Keskin M; Savaci N
J Craniofac Surg; 2014 May; 25(3):729-34. PubMed ID: 24481161
[TBL] [Abstract][Full Text] [Related]
17. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
[TBL] [Abstract][Full Text] [Related]
18. Modified procedure of anterior orbital exenteration enables eye socket reconstruction: A retrospective cohort study.
Ma R; Li X; Gan L; Guo J; Qian J
Medicine (Baltimore); 2022 Jan; 101(4):e28698. PubMed ID: 35089227
[TBL] [Abstract][Full Text] [Related]
19. Orbital exenteration for invasive skin tumours.
Tyers AG
Eye (Lond); 2006 Oct; 20(10):1165-70. PubMed ID: 17019414
[TBL] [Abstract][Full Text] [Related]
20. Mortality following exenteration for malignant tumours of the orbit.
Rahman I; Maino A; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Nov; 89(11):1445-8. PubMed ID: 16234450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
